Factor XI antagonists: the discovery of the philosopher's stone?
作者信息
De Vriese An S, Ledó Nóra
机构信息
Division of Nephrology and Infectious Diseases, AZ Sint-Jan Brugge, Brugge, Belgium.
Department of Internal Medicine, Ghent University, Ghent, Belgium.
出版信息
Clin Kidney J. 2024 Apr 22;17(5):sfae106. doi: 10.1093/ckj/sfae106. eCollection 2024 May.
Abstract
摘要
相似文献
1
Factor XI antagonists: the discovery of the philosopher's stone?
Clin Kidney J. 2024 Apr 22;17(5):sfae106. doi: 10.1093/ckj/sfae106. eCollection 2024 May.
2
The Philosopher's Stone the Subject of a Patent in the Fourteenth Century.
Med Exam (Phila). 1847 May;3(29):330.
3
A Philadelphia fable: how ideal occlusion became the philosopher's stone of orthodontics.
Int J Periodontics Restorative Dent. 2007 Oct;27(5):409-10.
4
The rejuvenation of testosterone: philosopher's stone or Brown-Séquard Elixir?
Ther Adv Endocrinol Metab. 2010 Aug;1(4):151-4. doi: 10.1177/2042018810385052.
5
[Psychiatry--the philosopher's stone?].
Ugeskr Laeger. 1962 Apr 13;124:518-20.
6
A philosopher's stone. Could superconductors transmute electromagnetic radiation into gravitational waves?
Sci Am. 2002 Jun;286(6):19-20.
7
Long tracheal replacement or the philosopher's stone.
Ann Cardiothorac Surg. 2020 Jan;9(1):58-59. doi: 10.21037/acs.2019.11.08.
8
Cellular senescence: Searching for the philosopher's stone.
J Eur Acad Dermatol Venereol. 2024 Jul;38 Suppl 4:3-4. doi: 10.1111/jdv.19824.
9
Alchemy in popular culture: Leonardo Fioravanti and the search for the philosopher's stone.
Early Sci Med. 2000 May;5(2):196-213. doi: 10.1163/157338200x00182.
10
Assessment of retinal arteriolar morphology by noninvasive methods: the philosopher's stone?
J Hypertens. 2016 Jun;34(6):1044-6. doi: 10.1097/HJH.0000000000000908.
引用本文的文献
1
Anticoagulation for Atrial Fibrillation in Kidney Failure: A Call to Arms.
J Am Soc Nephrol. 2025 May 1;36(5):763-765. doi: 10.1681/ASN.0000000682. Epub 2025 Mar 24.
2
Selected Updates in Anti-arrhythmic Drug Therapy and Anticoagulants: 2024.
J Innov Card Rhythm Manag. 2025 Jan 15;16(1):6144-6150. doi: 10.19102/icrm.2025.16018. eCollection 2025 Jan.
3
Ten tips to manage oral anticoagulation in hemodialysis patients with atrial fibrillation.
Clin Kidney J. 2024 Oct 4;17(10):sfae270. doi: 10.1093/ckj/sfae270. eCollection 2024 Oct.
本文引用的文献
1
A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysis.
Kidney Int. 2024 Jul;106(1):145-153. doi: 10.1016/j.kint.2024.02.024. Epub 2024 Mar 26.
2
Anticoagulation with osocimab in patients with kidney failure undergoing hemodialysis: a randomized phase 2 trial.
Nat Med. 2024 Feb;30(2):435-442. doi: 10.1038/s41591-023-02794-7. Epub 2024 Feb 16.
3
Thrombosis, Bleeding, and the Promise of Factor XI(a) Inhibition.
J Am Coll Cardiol. 2024 Feb 13;83(6):679-681. doi: 10.1016/j.jacc.2023.12.003.
4
Oral Anticoagulation in Patients With Advanced Chronic Kidney Disease and Atrial Fibrillation: Beyond Anticoagulation.
Mayo Clin Proc. 2023 May;98(5):750-770. doi: 10.1016/j.mayocp.2023.01.007. Epub 2023 Apr 5.
5
The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial.
Blood. 2021 Dec 2;138(22):2173-2184. doi: 10.1182/blood.2021011725.
6
Anticoagulation management in haemodialysis patients with atrial fibrillation: evidence and opinion.
Nephrol Dial Transplant. 2022 Oct 19;37(11):2072-2079. doi: 10.1093/ndt/gfab060.
Zotero 插件